Report

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 STUDY SCOPE 33
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED 35
1.3.3 CURRENCY CONSIDERED 35
1.4 STAKEHOLDERS 35
1.5 SUMMARY OF CHANGES 36
1.5.1 IMPACT OF AI/GEN AI 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY DATA 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 GLOBAL MARKET ESTIMATION 41
2.2.2 INSIGHTS FROM PRIMARY SOURCES 43
2.3 GROWTH RATE PROJECTIONS 44
2.4 DATA TRIANGULATION 46
2.5 RESEARCH ASSUMPTIONS 48
2.6 RESEARCH LIMITATIONS 48
2.7 RISK ANALYSIS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 54
4.1 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET OVERVIEW 54
4.2 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE & COUNTRY, 2023 55
4.3 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE 56
4.4 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER 56
4.5 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
?
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 DRIVERS 60
5.2.1.1 Increased investments in precision medicines 60
5.2.1.2 Rising demand for generic drugs 60
5.2.1.3 Need for affordable drug development 61
5.2.1.4 Favorable initiatives by contract development and manufacturing organizations 62
5.2.2 RESTRAINTS 63
5.2.2.1 Stringent regulatory requirements 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 Emergence of cell and gene therapies 63
5.2.3.2 Growing inclination toward one-stop-shop model 65
5.2.3.3 Growth opportunities in emerging countries 65
5.2.3.4 Booming nuclear medicine market 66
5.2.4 CHALLENGES 66
5.2.4.1 Introduction of serialization 66
5.2.4.2 Intellectual property risk 66
5.3 PRICING ANALYSIS 67
5.3.1 INDICATIVE PRICING ANALYSIS, BY SERVICE 67
5.3.2 INDICATIVE PRICING ANALYSIS, BY REGION 67
5.4 VALUE CHAIN ANALYSIS 68
5.5 SUPPLY CHAIN ANALYSIS 70
5.6 ECOSYSTEM ANALYSIS 72
5.7 TECHNOLOGY ANALYSIS 74
5.7.1 KEY TECHNOLOGIES 75
5.7.1.1 Single-use bioprocessing systems 75
5.7.1.2 Continuous manufacturing 75
5.7.1.3 Advanced formulation technologies 76
5.7.2 COMPLEMENTARY TECHNOLOGIES 76
5.7.2.1 High-performance liquid chromatography 76
5.7.2.2 Mass spectrometry 76
5.7.2.3 Next-generation sequencing 77
5.7.2.4 Automation and robotics 77
5.7.2.5 Process analytical technology 78
5.7.3 ADJACENT TECHNOLOGIES 78
5.7.3.1 3D printing 78
5.7.3.2 Artificial intelligence and machine learning 79
5.8 PORTER'S FIVE FORCES ANALYSIS 79
5.8.1 THREAT OF NEW ENTRANTS 80
5.8.2 THREAT OF SUBSTITUTES 80
5.8.3 BARGAINING POWER OF SUPPLIERS 81
5.8.4 BARGAINING POWER OF BUYERS 81
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.9 REGULATORY LANDSCAPE 81
5.9.1 REGULATORY SCENARIO 81
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
5.10 KEY CONFERENCES AND EVENTS, 2024-2025 88
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 89
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
5.11.2 BUYING CRITERIA 90
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 91
5.13 ABBREVIATED NEW DRUG APPLICATION (ANDA) APPROVALS 91
5.14 INVESTMENT AND FUNDING SCENARIO 93
5.15 IMPACT OF AI/GEN AI ON PHARMACEUTICAL CONTRACT MANUFACTURING MARKET 94
6 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE 96
6.1 INTRODUCTION 97
6.2 PHARMACEUTICAL MANUFACTURING SERVICES 97
6.2.1 PHARMACEUTICAL API MANUFACTURING SERVICES 101
6.2.1.1 Rising cases of patent expiry to fuel market 101
6.2.2 PHARMACEUTICAL FDF MANUFACTURING SERVICES 105
6.2.2.1 Parenteral manufacturing services 109
6.2.2.1.1 Increasing demand for specialized manufacturing capabilities to support market growth 109
6.2.2.2 Tablet manufacturing services 112
6.2.2.2.1 Growing domestic production capacity in emerging markets to accelerate growth 112
6.2.2.3 Capsule manufacturing services 116
6.2.2.3.1 Rising adoption in pharmaceutical, nutraceutical, and cosmetic applications to stimulate growth 116
6.2.2.4 Oral liquid manufacturing services 119
6.2.2.4.1 Growing preference for oral liquids over powders to facilitate growth 119
6.2.2.5 Semi-solid manufacturing services 123
6.2.2.5.1 Rising prevalence of skin infections and burns to propel market 123
6.2.2.6 Other FDF manufacturing services 126
6.3 DRUG DEVELOPMENT SERVICES 130
6.3.1 INCREASING COST OF DRUG DISCOVERY AND DEVELOPMENT TO EXPEDITE GROWTH 130
?
6.4 BIOLOGICS MANUFACTURING SERVICES 133
6.4.1 BIOLOGICS API MANUFACTURING SERVICES 137
6.4.1.1 Expanding offerings in cell line development and production to aid market growth 137
6.4.2 BIOLOGICS FDF MANUFACTURING SERVICES 140
6.4.2.1 Growing importance due to therapeutic potential to encourage growth 140
6.5 PACKAGING & LABELING SERVICES 144
6.5.1 INCREASING STRINGENCY OF REGULATORY REQUIREMENTS FOR DRUG SAFETY AND EFFICACY TO FAVOR MARKET GROWTH 144
6.6 FILL-FINISH SERVICES 147
6.6.1 SURGE IN DEMAND FOR BIOLOGICS AND COMPLEX INJECTABLE THERAPIES TO DRIVE MARKET 147
6.7 OTHER SERVICES 151
7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER 155
7.1 INTRODUCTION 156
7.2 BIG PHARMACEUTICAL COMPANIES 156
7.2.1 RISING PRICING PRESSURE IN PHARMACEUTICAL INDUSTRY TO CONTRIBUTE TO MARKET GROWTH 156
7.3 SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES 160
7.3.1 NEED TO SAVE COSTS ON IN-HOUSE DRUG MANUFACTURING
TO BOOST MARKET 160
7.4 GENERIC PHARMACEUTICAL COMPANIES 164
7.4.1 FAVORABLE GOVERNMENT SUPPORT FOR ADOPTION OF GENERIC DRUGS
TO PROPEL MARKET 164
7.5 OTHER END USERS 168
8 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION 171
8.1 INTRODUCTION 172
8.2 NORTH AMERICA 173
8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 176
8.2.2 US 177
8.2.2.1 Presence of major pharmaceutical companies to drive market 177
8.2.3 CANADA 180
8.2.3.1 Favorable government support to sustain market growth 180
8.3 EUROPE 183
8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 186
8.3.2 GERMANY 187
8.3.2.1 Free drug pricing policy to speed up market growth 187
8.3.3 UK 190
8.3.3.1 Favorable R&D funding scenario to augment growth 190
8.3.4 FRANCE 193
8.3.4.1 Booming life science research to fuel market 193
8.3.5 ITALY 196
8.3.5.1 Rising commercial drug development to favor growth 196
8.3.6 SWITZERLAND 199
8.3.6.1 Role as global pharmaceutical manufacturing hub to fuel market 199
8.3.7 POLAND 202
8.3.7.1 Universal health coverage and advanced infrastructure to encourage growth 202
8.3.8 SPAIN 205
8.3.8.1 Growing outsourcing of development and trial phases to boost market 205
8.3.9 REST OF EUROPE 208
8.4 ASIA PACIFIC 211
8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 215
8.4.2 CHINA 216
8.4.2.1 Made in China 2025 initiative to aid market growth 216
8.4.3 INDIA 220
8.4.3.1 Favorable industrial environment and lower labor costs to drive market 220
8.4.4 AUSTRALIA 222
8.4.4.1 Strategic geographical location to foster growth 222
8.4.5 JAPAN 225
8.4.5.1 Growing geriatric population to augment growth 225
8.4.6 SOUTH KOREA 228
8.4.6.1 Initiatives for enhanced workforce, improved regulations, and R&D for new drugs to promote growth 228
8.4.7 REST OF ASIA PACIFIC 231
8.5 LATIN AMERICA 234
8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 237
8.5.2 BRAZIL 238
8.5.2.1 Rapid patient enrolment and presence of highly experienced investigators for clinical trials to expedite growth 238
8.5.3 MEXICO 241
8.5.3.1 Surge in pharmaceutical goods export to promote growth 241
8.5.4 REST OF LATIN AMERICA 244
8.6 MIDDLE EAST 247
8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 250
8.6.2 GCC COUNTRIES 251
8.6.2.1 Kingdom of Saudi Arabia 254
8.6.2.1.1 Growing focus on enhanced healthcare expenditure to aid market growth 254
8.6.2.2 UAE 257
8.6.2.2.1 Growing population and healthcare spending to drive market 257
8.6.2.3 Other GCC Countries 260
8.6.3 REST OF MIDDLE EAST 263
8.7 AFRICA 266
8.7.1 RISING CASES OF CANCER AND OTHER CHRONIC DISEASES TO FACILITATE GROWTH 266
8.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 269
9 COMPETITIVE LANDSCAPE 270
9.1 INTRODUCTION 270
9.2 KEY PLAYER STRATEGY/RIGHT TO WIN 270
9.3 REVENUE ANALYSIS 274
9.4 MARKET SHARE ANALYSIS 275
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 278
9.5.1 STARS 278
9.5.2 EMERGING LEADERS 278
9.5.3 PERVASIVE PLAYERS 278
9.5.4 PARTICIPANTS 278
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 280
9.5.5.1 Company footprint 280
9.5.5.2 Service footprint 281
9.5.5.3 End-user footprint 282
9.5.5.4 Region footprint 283
9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 284
9.6.1 PROGRESSIVE COMPANIES 284
9.6.2 RESPONSIVE COMPANIES 284
9.6.3 DYNAMIC COMPANIES 284
9.6.4 STARTING BLOCKS 285
9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 286
9.7 BRAND/SERVICE COMPARISON 288
9.7.1 THERMO FISHER SCIENTIFIC INC. 289
9.7.2 CATALENT, INC. 289
9.7.3 LONZA 289
9.7.4 SAMSUNG BIOLOGICS 289
9.7.5 WUXI APPTEC 289
9.8 COMPANY VALUATION AND FINANCIAL METRICS 290
9.9 COMPETITIVE SCENARIO 291
9.9.1 SERVICE LAUNCHES 291
9.9.2 DEALS 292
9.9.3 EXPANSIONS 293
?
10 COMPANY PROFILES 294
10.1 KEY PLAYERS 294
10.1.1 THERMO FISHER SCIENTIFIC INC. 294
10.1.1.1 Business overview 294
10.1.1.2 Services offered 295
10.1.1.3 Recent developments 296
10.1.1.3.1 Service launches 296
10.1.1.3.2 Deals 297
10.1.1.3.3 Expansions 298
10.1.1.4 MnM view 298
10.1.1.4.1 Key strengths 298
10.1.1.4.2 Strategic choices 298
10.1.1.4.3 Weaknesses and competitive threats 298
10.1.2 LONZA 299
10.1.2.1 Business overview 299
10.1.2.2 Services offered 301
10.1.2.3 Recent developments 302
10.1.2.3.1 Deals 302
10.1.2.4 MnM view 305
10.1.2.4.1 Key strengths 305
10.1.2.4.2 Strategic choices 305
10.1.2.4.3 Weaknesses and competitive threats 306
10.1.3 CATALENT, INC. 307
10.1.3.1 Business overview 307
10.1.3.2 Services offered 309
10.1.3.3 Recent developments 311
10.1.3.3.1 Service launches 311
10.1.3.3.2 Deals 311
10.1.3.3.3 Expansions 313
10.1.3.4 MnM view 314
10.1.3.4.1 Key strengths 314
10.1.3.4.2 Strategic choices 314
10.1.3.4.3 Weaknesses and competitive threats 314
10.1.4 WUXI APPTEC 315
10.1.4.1 Business overview 315
10.1.4.2 Services offered 317
10.1.4.3 Recent developments 317
10.1.4.3.1 Deals 317
10.1.4.3.2 Expansions 318
10.1.4.4 MnM view 319
10.1.4.4.1 Key strengths 319
10.1.4.4.2 Strategic choices 319
10.1.4.4.3 Weaknesses and competitive threats 319
10.1.5 WUXI BIOLOGICS 320
10.1.5.1 Business overview 320
10.1.5.2 Services offered 321
10.1.5.3 Recent developments 322
10.1.5.3.1 Deals 322
10.1.5.3.2 Expansions 323
10.1.6 SAMSUNG BIOLOGICS 324
10.1.6.1 Business overview 324
10.1.6.2 Services offered 325
10.1.6.3 Recent developments 325
10.1.6.3.1 Deals 325
10.1.6.3.2 Expansions 326
10.1.7 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 327
10.1.7.1 Business overview 327
10.1.7.2 Services offered 329
10.1.7.3 Recent developments 329
10.1.7.3.1 Deals 329
10.1.7.3.2 Expansions 330
10.1.8 EVONIK INDUSTRIES AG 331
10.1.8.1 Business overview 331
10.1.8.2 Services offered 333
10.1.8.3 Recent developments 333
10.1.8.3.1 Deals 333
10.1.8.3.2 Expansions 334
10.1.9 FUJIFILM HOLDINGS CORPORATION 335
10.1.9.1 Business overview 335
10.1.9.2 Services offered 336
10.1.9.3 Recent developments 338
10.1.9.3.1 Deals 338
10.1.9.3.2 Expansions 339
10.1.10 ABBVIE INC. 340
10.1.10.1 Business overview 340
10.1.10.2 Services offered 341
10.1.10.3 Recent developments 342
10.1.10.3.1 Deals 342
10.1.10.3.2 Expansions 343
10.1.11 SIEGFRIED HOLDING AG 344
10.1.11.1 Business overview 344
10.1.11.2 Services offered 345
10.1.11.3 Recent developments 346
10.1.11.3.1 Deals 346
10.1.11.3.2 Expansions 346
10.1.12 MERCK KGAA 347
10.1.12.1 Business overview 347
10.1.12.2 Services offered 349
10.1.12.3 Recent developments 349
10.1.12.3.1 Deals 349
10.1.12.3.2 Expansions 350
10.1.13 ALMAC GROUP 351
10.1.13.1 Business overview 351
10.1.13.2 Services offered 351
10.1.13.3 Recent developments 353
10.1.13.3.1 Deals 353
10.1.13.3.2 Expansions 353
10.1.14 CHARLES RIVER LABORATORIES 355
10.1.14.1 Business overview 355
10.1.14.2 Services offered 355
10.1.14.3 Recent developments 356
10.1.14.3.1 Deals 356
10.1.14.3.2 Expansions 356
10.1.15 ASYMCHEM INC. 357
10.1.15.1 Business overview 357
10.1.15.2 Services offered 358
10.1.15.3 Recent developments 359
10.1.15.3.1 Deals 359
10.1.15.3.2 Expansions 359
10.1.16 VETTER PHARMA 360
10.1.16.1 Business overview 360
10.1.16.2 Services offered 360
10.1.16.3 Recent developments 361
10.1.16.3.1 Deals 361
10.1.16.3.2 Expansions 361
10.1.17 ALCAMI CORPORATION 362
10.1.17.1 Business overview 362
10.1.17.2 Services offered 363
10.1.17.3 Recent developments 363
10.1.17.3.1 Deals 363
10.1.17.3.2 Expansions 364
10.2 OTHER PLAYERS 365
10.2.1 PIRAMAL PHARMA SOLUTIONS 365
10.2.2 SYNGENE INTERNATIONAL LIMITED 366
10.2.3 CAMBREX CORPORATION 367
10.2.4 JUBILANT BIOSYS LTD. 368
10.2.5 YUHAN CORPORATION 369
10.2.6 PIERRE FABRE GROUP 370
10.2.7 PFIZER CENTREONE 371
10.2.8 DELPHARM 372
10.2.9 FRONTAGE LABS 373
10.2.10 SHARP SERVICES, LLC 374
10.2.11 GRAND RIVER ASEPTIC MANUFACTURING 375
11 APPENDIX 376
11.1 DISCUSSION GUIDE 376
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 380
11.3 CUSTOMIZATION OPTIONS 382
11.4 RELATED REPORTS 383
11.5 AUTHOR DETAILS 384

TABLE 1 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: INCLUSIONS AND EXCLUSIONS 33
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 45
TABLE 3 PHARMACEUTICAL CONTRACT MANUFACTURING AND DEVELOPMENT MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 59
TABLE 4 IMPENDING PATENT EXPIRY OF DRUGS, BY YEAR 61
TABLE 5 EXPANSIONS BY TOP COMPANIES, 2022-2024 64
TABLE 6 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET:
ROLE OF COMPANIES IN SUPPLY CHAIN 71
TABLE 7 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET:
ROLE OF COMPANIES IN ECOSYSTEM 73
TABLE 8 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET:
PORTER'S FIVE FORCES ANALYSIS 79
TABLE 9 REGULATORY SCENARIO, BY COUNTRY 82
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 85
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 86
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 86
TABLE 14 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 87
TABLE 15 AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 87
TABLE 16 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET:
KEY CONFERENCES AND EVENTS, 2024-2025 88
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SERVICE TYPE 89
TABLE 18 BUYING CRITERIA FOR PHARMACEUTICAL CONTRACT MANUFACTURING,
BY END USER 90
TABLE 19 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD BILLION) 97
TABLE 20 PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 98
TABLE 21 PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 98
TABLE 22 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 99
TABLE 23 EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 99
TABLE 24 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 100
TABLE 25 LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 100
TABLE 26 MIDDLE EAST: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 101
TABLE 27 GCC COUNTRIES: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 101
TABLE 28 PHARMACEUTICAL API MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 102
TABLE 29 NORTH AMERICA: PHARMACEUTICAL API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 102
TABLE 30 EUROPE: PHARMACEUTICAL API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 103
TABLE 31 ASIA PACIFIC: PHARMACEUTICAL API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 103
TABLE 32 LATIN AMERICA: PHARMACEUTICAL API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 104
TABLE 33 MIDDLE EAST: PHARMACEUTICAL API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 104
TABLE 34 GCC COUNTRIES: PHARMACEUTICAL API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 104
TABLE 35 PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 105
TABLE 36 PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 106
TABLE 37 NORTH AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 106
TABLE 38 EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 107
TABLE 39 ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 107
TABLE 40 LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 108
TABLE 41 MIDDLE EAST: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 108
TABLE 42 GCC COUNTRIES: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 108
TABLE 43 PARENTERAL MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 109
TABLE 44 NORTH AMERICA: PARENTERAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 110
TABLE 45 EUROPE: PARENTERAL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 110
TABLE 46 ASIA PACIFIC: PARENTERAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 111
TABLE 47 LATIN AMERICA: PARENTERAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 111
TABLE 48 MIDDLE EAST: PARENTERAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 112
TABLE 49 GCC COUNTRIES: PARENTERAL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 112
TABLE 50 TABLET MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 113
TABLE 51 NORTH AMERICA: TABLET MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 113
TABLE 52 EUROPE: TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 114
TABLE 53 ASIA PACIFIC: TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 114
TABLE 54 LATIN AMERICA: TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 115
TABLE 55 MIDDLE EAST: TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 115
TABLE 56 GCC COUNTRIES: TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 115
TABLE 57 CAPSULE MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 116
TABLE 58 NORTH AMERICA: CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 117
TABLE 59 EUROPE: CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 117
TABLE 60 ASIA PACIFIC: CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 118
TABLE 61 LATIN AMERICA: CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 118
TABLE 62 MIDDLE EAST: CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 118
TABLE 63 GCC COUNTRIES: CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 119
TABLE 64 ORAL LIQUID MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 120
TABLE 65 NORTH AMERICA: ORAL LIQUID MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 120
TABLE 66 EUROPE: ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 121
TABLE 67 ASIA PACIFIC: ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 121
TABLE 68 LATIN AMERICA: ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 122
TABLE 69 MIDDLE EAST: ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 122
TABLE 70 GCC COUNTRIES: ORAL LIQUID MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 122
TABLE 71 SEMI-SOLID MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 123
TABLE 72 NORTH AMERICA: SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 124
TABLE 73 EUROPE: SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 124
TABLE 74 ASIA PACIFIC: SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 125
TABLE 75 LATIN AMERICA: SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 125
TABLE 76 MIDDLE EAST: SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 126
TABLE 77 GCC COUNTRIES: SEMI-SOLID MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 126
TABLE 78 OTHER FDF MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 127
TABLE 79 NORTH AMERICA: OTHER FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 127
TABLE 80 EUROPE: OTHER FDF MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 128
TABLE 81 ASIA PACIFIC: OTHER FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 128
TABLE 82 LATIN AMERICA: OTHER FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 129
TABLE 83 MIDDLE EAST: OTHER FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 129
TABLE 84 GCC COUNTRIES: OTHER FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 129
TABLE 85 DRUG DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD BILLION) 130
TABLE 86 NORTH AMERICA: DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 131
TABLE 87 EUROPE: DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 131
TABLE 88 ASIA PACIFIC: DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 132
TABLE 89 LATIN AMERICA: DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 132
TABLE 90 MIDDLE EAST: DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 132
TABLE 91 GCC COUNTRIES: DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 133
TABLE 92 BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 134
TABLE 93 BIOLOGICS MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 134
TABLE 94 NORTH AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 134
TABLE 95 EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 135
TABLE 96 ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 135
TABLE 97 LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 136
TABLE 98 MIDDLE EAST: BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 136
TABLE 99 GCC COUNTRIES: BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 136
TABLE 100 BIOLOGICS API MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 137
TABLE 101 NORTH AMERICA: BIOLOGICS API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 138
TABLE 102 EUROPE: BIOLOGICS API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 138
TABLE 103 ASIA PACIFIC: BIOLOGICS API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 139
TABLE 104 LATIN AMERICA: BIOLOGICS API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 139
TABLE 105 MIDDLE EAST: BIOLOGICS API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 139
TABLE 106 GCC COUNTRIES: BIOLOGICS API MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 140
TABLE 107 BIOLOGICS FDF MANUFACTURING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 141
TABLE 108 NORTH AMERICA: BIOLOGICS FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 141
TABLE 109 EUROPE: BIOLOGICS FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 142
TABLE 110 ASIA PACIFIC: BIOLOGICS FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 142
TABLE 111 LATIN AMERICA: BIOLOGICS FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 143
TABLE 112 MIDDLE EAST: BIOLOGICS FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 143
TABLE 113 GCC COUNTRIES: BIOLOGICS FDF MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 143
TABLE 114 PACKAGING & LABELING SERVICES MARKET, BY REGION,
2022-2029 (USD BILLION) 144
TABLE 115 NORTH AMERICA: PACKAGING & LABELING SERVICES MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 145
TABLE 116 EUROPE: PACKAGING & LABELING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 145
TABLE 117 ASIA PACIFIC: PACKAGING & LABELING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 146
TABLE 118 LATIN AMERICA: PACKAGING & LABELING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 146
TABLE 119 MIDDLE EAST: PACKAGING & LABELING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 146
TABLE 120 GCC COUNTRIES: PACKAGING & LABELING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 147
TABLE 121 FILL-FINISH SERVICES MARKET, BY REGION, 2022-2029 (USD BILLION) 148
TABLE 122 NORTH AMERICA: FILL-FINISH SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 148
TABLE 123 EUROPE: FILL-FINISH SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 149
TABLE 124 ASIA PACIFIC: FILL-FINISH SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 149
TABLE 125 LATIN AMERICA: FILL-FINISH SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 150
TABLE 126 MIDDLE EAST: FILL-FINISH SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 150
TABLE 127 GCC COUNTRIES: FILL-FINISH SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 150
TABLE 128 OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD BILLION) 151
TABLE 129 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 152
TABLE 130 EUROPE: OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 152
TABLE 131 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 153
TABLE 132 LATIN AMERICA: OTHER SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 153
TABLE 133 MIDDLE EAST: OTHER SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 153
TABLE 134 GCC COUNTRIES: OTHER SERVICES MARKET, BY COUNTRY,
2022-2029 (USD BILLION) 154
TABLE 135 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 156
TABLE 136 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 157
TABLE 137 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 158
TABLE 138 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 158
TABLE 139 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 159
TABLE 140 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 159
TABLE 141 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 159
TABLE 142 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD BILLION) 160
TABLE 143 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD BILLION) 161
TABLE 144 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 161
TABLE 145 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 162
TABLE 146 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 162
TABLE 147 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 163
TABLE 148 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 163
TABLE 149 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 163
TABLE 150 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD BILLION) 165
TABLE 151 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 165
TABLE 152 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 166
TABLE 153 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 166
TABLE 154 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 167
TABLE 155 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY,
2022-2029 (USD BILLION) 167
TABLE 156 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR GENERIC PHARMACEUTICAL COMPANIES BY COUNTRY, 2022-2029 (USD BILLION) 167
TABLE 157 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD BILLION) 168
TABLE 158 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD BILLION) 168
TABLE 159 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD BILLION) 169
TABLE 160 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD BILLION) 169
TABLE 161 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD BILLION) 170
TABLE 162 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD BILLION) 170
TABLE 163 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD BILLION) 170
TABLE 164 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION,
2022-2029 (USD BILLION) 172
TABLE 165 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 174
TABLE 166 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 174
TABLE 167 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 175
TABLE 168 NORTH AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 175
TABLE 169 NORTH AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 176
TABLE 170 NORTH AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 176
TABLE 171 US: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD BILLION) 178
TABLE 172 US: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 178
TABLE 173 US: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 179
TABLE 174 US: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 179
TABLE 175 US: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 180
TABLE 176 CANADA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 181
TABLE 177 CANADA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 181
TABLE 178 CANADA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 182
TABLE 179 CANADA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 182
TABLE 180 CANADA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 183
TABLE 181 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2022-2029 (USD BILLION) 184
TABLE 182 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 184
TABLE 183 EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 185
TABLE 184 EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 185
TABLE 185 EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 186
TABLE 186 EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 186
TABLE 187 GERMANY: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 188
TABLE 188 GERMANY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 188
TABLE 189 GERMANY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 189
TABLE 190 GERMANY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 189
TABLE 191 GERMANY: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 190
TABLE 192 UK: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE,
2022-2029 (USD BILLION) 191
TABLE 193 UK: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 191
TABLE 194 UK: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 192
TABLE 195 UK: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 192
TABLE 196 UK: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 193
TABLE 197 FRANCE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 194
TABLE 198 FRANCE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 194
TABLE 199 FRANCE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 195
TABLE 200 FRANCE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 195
TABLE 201 FRANCE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 196
TABLE 202 ITALY: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 197
TABLE 203 ITALY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 197
TABLE 204 ITALY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 198
TABLE 205 ITALY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 198
TABLE 206 ITALY: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 199
TABLE 207 SWITZERLAND: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 200
TABLE 208 SWITZERLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 200
TABLE 209 SWITZERLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 201
TABLE 210 SWITZERLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 201
TABLE 211 SWITZERLAND: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 202
TABLE 212 POLAND: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 203
TABLE 213 POLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 203
TABLE 214 POLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 204
TABLE 215 POLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 204
TABLE 216 POLAND: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 205
TABLE 217 SPAIN: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 206
TABLE 218 SPAIN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 206
TABLE 219 SPAIN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 207
TABLE 220 SPAIN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 207
TABLE 221 SPAIN: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 208
TABLE 222 REST OF EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 209
TABLE 223 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 209
TABLE 224 REST OF EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 210
TABLE 225 REST OF EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 210
TABLE 226 REST OF EUROPE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 211
TABLE 227 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 213
TABLE 228 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 213
TABLE 229 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 214
TABLE 230 ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 214
TABLE 231 ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 215
TABLE 232 ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 215
TABLE 233 CHINA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 217
TABLE 234 CHINA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 218
TABLE 235 CHINA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 218
TABLE 236 CHINA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 219
TABLE 237 CHINA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 219
TABLE 238 INDIA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 220
TABLE 239 INDIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 221
TABLE 240 INDIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 221
TABLE 241 INDIA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 222
TABLE 242 INDIA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 222
TABLE 243 AUSTRALIA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 223
TABLE 244 AUSTRALIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 224
TABLE 245 AUSTRALIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 224
TABLE 246 AUSTRALIA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 225
TABLE 247 AUSTRALIA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 225
TABLE 248 JAPAN: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 226
TABLE 249 JAPAN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 226
TABLE 250 JAPAN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 227
TABLE 251 JAPAN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 227
TABLE 252 JAPAN: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 228
TABLE 253 SOUTH KOREA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 229
TABLE 254 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 229
TABLE 255 SOUTH KOREA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 230
TABLE 256 SOUTH KOREA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 230
TABLE 257 SOUTH KOREA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 231

TABLE 258 REST OF ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 232
TABLE 259 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 232
TABLE 260 REST OF ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 233
TABLE 261 REST OF ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 233
TABLE 262 REST OF ASIA PACIFIC: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 234
TABLE 263 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY COUNTRY, 2022-2029 (USD BILLION) 235
TABLE 264 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 235
TABLE 265 LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 236
TABLE 266 LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 236
TABLE 267 LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 237
TABLE 268 LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 237
TABLE 269 BRAZIL: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 239
TABLE 270 BRAZIL: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 239
TABLE 271 BRAZIL: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 240
TABLE 272 BRAZIL: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 240
TABLE 273 BRAZIL: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 241
TABLE 274 MEXICO: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 242
TABLE 275 MEXICO: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 242
TABLE 276 MEXICO: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 243
TABLE 277 MEXICO: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 243
TABLE 278 MEXICO: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 244
TABLE 279 REST OF LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 245
TABLE 280 REST OF LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 245
TABLE 281 REST OF LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 246
TABLE 282 REST OF LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 246
TABLE 283 REST OF LATIN AMERICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 247
TABLE 284 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 248
TABLE 285 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 248
TABLE 286 MIDDLE EAST: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 249
TABLE 287 MIDDLE EAST: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 249
TABLE 288 MIDDLE EAST: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 250
TABLE 289 MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 250
TABLE 290 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 251
TABLE 291 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY SERVICE, 2022-2029 (USD BILLION) 252
TABLE 292 GCC COUNTRIES: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 252
TABLE 293 GCC COUNTRIES: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 253
TABLE 294 GCC COUNTRIES: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 253
TABLE 295 GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 254
TABLE 296 KINGDOM OF SAUDI ARABIA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 255
TABLE 297 KINGDOM OF SAUDI ARABIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 255
TABLE 298 KINGDOM OF SAUDI ARABIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 256
TABLE 299 KINGDOM OF SAUDI ARABIA: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 256
TABLE 300 KINGDOM OF SAUDI ARABIA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 257
TABLE 301 UAE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 258
TABLE 302 UAE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 258
TABLE 303 UAE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 259
TABLE 304 UAE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 259
TABLE 305 UAE: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 260
TABLE 306 OTHER GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 261
TABLE 307 OTHER GCC COUNTRIES: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 261
TABLE 308 OTHER GCC COUNTRIES: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 262
TABLE 309 OTHER GCC COUNTRIES: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 262
TABLE 310 OTHER GCC COUNTRIES: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 263
TABLE 311 REST OF MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 264
TABLE 312 REST OF MIDDLE EAST: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 264
TABLE 313 REST OF MIDDLE EAST: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 265
TABLE 314 REST OF MIDDLE EAST: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2022-2029 (USD BILLION) 265
TABLE 315 REST OF MIDDLE EAST: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER, 2022-2029 (USD BILLION) 266
TABLE 316 AFRICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD BILLION) 267
TABLE 317 AFRICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 267
TABLE 318 AFRICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2022-2029 (USD BILLION) 268
TABLE 319 AFRICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2022-2029 (USD BILLION) 268
TABLE 320 AFRICA: PHARMACEUTICAL CONTRACT MANUFACTURING MARKET,
BY END USER, 2022-2029 (USD BILLION) 269
TABLE 321 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET 270
TABLE 322 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET:
DEGREE OF COMPETITION 276
TABLE 323 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SERVICE FOOTPRINT 281
TABLE 324 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: END-USER FOOTPRINT 282
TABLE 325 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: REGION FOOTPRINT 283
TABLE 326 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 286
TABLE 327 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 287
TABLE 328 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SERVICE LAUNCHES, JANUARY 2021-JULY 2024 291
TABLE 329 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: DEALS,
JANUARY 2021-JULY 2024 292
TABLE 330 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET:
EXPANSIONS, JANUARY 2021-JULY 2024 293
TABLE 331 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 294
TABLE 332 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 295
TABLE 333 THERMO FISHER SCIENTIFIC INC.: SERVICE LAUNCHES,
JANUARY 2021-JULY 2024 296
TABLE 334 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-JULY 2024 297
TABLE 335 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-JULY 2024 298
TABLE 336 LONZA: COMPANY OVERVIEW 299
TABLE 337 LONZA: SERVICES OFFERED 301
TABLE 338 LONZA: DEALS, JANUARY 2021-JULY 2024 302
TABLE 339 LONZA: EXPANSIONS, JANUARY 2021-JULY 2024 304
TABLE 340 CATALENT, INC.: COMPANY OVERVIEW 307
TABLE 341 CATALENT, INC.: SERVICES OFFERED 309
TABLE 342 CATALENT, INC.: SERVICE LAUNCHES, JANUARY 2021-JULY 2024 311
TABLE 343 CATALENT, INC.: DEALS, JANUARY 2021-JULY 2024 311
TABLE 344 CATALENT, INC.: EXPANSIONS, JANUARY 2021-JULY 2024 313
TABLE 345 WUXI APPTEC: COMPANY OVERVIEW 315
TABLE 346 WUXI APPTEC: SERVICES OFFERED 317
TABLE 347 WUXI APPTEC: DEALS, JANUARY 2021-JULY 2024 317
TABLE 348 WUXI APPTEC: EXPANSIONS, JANUARY 2021-JULY 2024 318
TABLE 349 WUXI BIOLOGICS: COMPANY OVERVIEW 320
TABLE 350 WUXI BIOLOGICS: SERVICES OFFERED 321
TABLE 351 WUXI BIOLOGICS: DEALS, JANUARY 2021-JULY 2024 322
TABLE 352 WUXI BIOLOGICS: EXPANSIONS, JANUARY 2021-JULY 2024 323
TABLE 353 SAMSUNG BIOLOGICS: COMPANY OVERVIEW 324
TABLE 354 SAMSUNG BIOLOGICS: SERVICES OFFERED 325
TABLE 355 SAMSUNG BIOLOGICS: DEALS, JANUARY 2021-JULY 2024 325
TABLE 356 SAMSUNG BIOLOGICS: EXPANSIONS, JANUARY 2021-JULY 2024 326
TABLE 357 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW 327
TABLE 358 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SERVICES OFFERED 329
TABLE 359 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS,
JANUARY 2021-JULY 2024 329
TABLE 360 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: EXPANSIONS,
JANUARY 2021-JULY 2024 330
TABLE 361 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 331
TABLE 362 EVONIK INDUSTRIES AG: SERVICES OFFERED 333
TABLE 363 EVONIK INDUSTRIES AG: DEALS, JANUARY 2021-JULY 2024 333
TABLE 364 EVONIK INDUSTRIES AG: EXPANSIONS, JANUARY 2021-JULY 2024 334
TABLE 365 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 335
TABLE 366 FUJIFILM HOLDINGS CORPORATION: SERVICES OFFERED 336
TABLE 367 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021-JULY 2024 338
TABLE 368 FUJIFILM HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021-JULY 2024 339
TABLE 369 ABBVIE INC.: COMPANY OVERVIEW 340
TABLE 370 ABBVIE INC.: SERVICES OFFERED 341
TABLE 371 ABBVIE INC.: DEALS, JANUARY 2021-JULY 2024 342
TABLE 372 ABBVIE INC.: EXPANSIONS, JANUARY 2021-JULY 2024 343
TABLE 373 SIEGFRIED HOLDING AG: COMPANY OVERVIEW 344
TABLE 374 SIEGFRIED HOLDING AG: SERVICES OFFERED 345
TABLE 375 SIEGFRIED HOLDING AG: DEALS, JANUARY 2021-JULY 2024 346
TABLE 376 SIEGFRIED HOLDING AG: EXPANSIONS, JANUARY 2021-JULY 2024 346
TABLE 377 MERCK KGAA: COMPANY OVERVIEW 347
TABLE 378 MERCK KGAA: SERVICES OFFERED 349
TABLE 379 MERCK KGAA: DEALS, JANUARY 2021-JUNE 2024 349
TABLE 380 MERCK KGAA: EXPANSIONS, JANUARY 2021-JUNE 2024 350
TABLE 381 ALMAC GROUP: COMPANY OVERVIEW 351
TABLE 382 ALMAC GROUP: SERVICES OFFERED 351
TABLE 383 ALMAC GROUP: DEALS, JANUARY 2021-JULY 2024 353
TABLE 384 ALMAC GROUP: EXPANSIONS, JANUARY 2021-JULY 2024 353
TABLE 385 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 355
TABLE 386 CHARLES RIVER LABORATORIES: SERVICES OFFERED 355
TABLE 387 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-JULY 2024 356
TABLE 388 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021-JULY 2024 356
TABLE 389 ASYMCHEM INC.: COMPANY OVERVIEW 357
TABLE 390 ASYMCHEM INC.: SERVICES OFFERED 358
TABLE 391 ASYMCHEM INC.: DEALS, JANUARY 2021-JUNE 2024 359
TABLE 392 ASYMCHEM INC.: EXPANSIONS, JANUARY 2021-JUNE 2024 359
TABLE 393 VETTER PHARMA: COMPANY OVERVIEW 360
TABLE 394 VETTER PHARMA: SERVICES OFFERED 360
TABLE 395 VETTER PHARMA: DEALS, JANUARY 2021-JULY 2024 361
TABLE 396 VETTER PHARMA: EXPANSIONS, JANUARY 2021-JULY 2024 361
TABLE 397 ALCAMI CORPORATION: COMPANY OVERVIEW 362
TABLE 398 ALCAMI CORPORATION: SERVICES OFFERED 363
TABLE 399 ALCAMI CORPORATION: DEALS, JANUARY 2021-JULY 2024 363
TABLE 400 ALCAMI CORPORATION: EXPANSIONS, JANUARY 2021-JULY 2024 364
TABLE 401 PIRAMAL PHARMA SOLUTIONS: COMPANY OVERVIEW 365
TABLE 402 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 366
TABLE 403 CAMBREX CORPORATION: COMPANY OVERVIEW 367
TABLE 404 JUBILANT BIOSYS LTD.: COMPANY OVERVIEW 368
TABLE 405 YUHAN CORPORATION: COMPANY OVERVIEW 369
TABLE 406 PIERRE FABRE GROUP: COMPANY OVERVIEW 370
TABLE 407 PFIZER CENTREONE: COMPANY OVERVIEW 371
TABLE 408 DELPHARM: COMPANY OVERVIEW 372
TABLE 409 FRONTAGE LABS: COMPANY OVERVIEW 373
TABLE 410 SHARP SERVICES, LLC: COMPANY OVERVIEW 374
TABLE 411 GRAND RIVER ASEPTIC MANUFACTURING: COMPANY OVERVIEW 375